March 5, 2024
Japan’s health ministry on March 5 announced new NHI prices for listed medicines, effective April 1, revealing a 15.0% reduction for Ono Pharmaceutical’s immune checkpoint inhibitor Opdivo (nivolumab) in a spillover from the market expansion re-pricing of another medicine in...read more